Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder

Mariani, J. J., Basaraba, C., Pavlicova, M., Alschuler, D. M., Brooks, D. J., Mahony, A. L., Brezing, C., Naqvi, N. H., & Levin, F. R. (2023). Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder. The American Journal of Drug and Alcohol Abuse, 49(5), 618–629. https://doi.org/10.1080/00952990.2023.2241981
Authors:
John J Mariani
Cale Basaraba
Martina Pavlicova
Daniel M Alschuler
Daniel J Brooks
Amy L Mahony
Christina Brezing
Nasir H Naqvi
Frances R Levin
Affiliated Authors:
John J Mariani
Martina Pavlicova
Christina Brezing
Nasir H Naqvi
Frances R Levin
Columbia Affiliation:
Subjects:
Opioid-Related Disorders (MeSH)
Substance Withdrawal Syndrome (MeSH)
Author Keywords:
lofexidine
naltrexone
opioid use disorder
pharmacotherapy
elink
Publication Type:
Article
Unique ID:
10.1080/00952990.2023.2241981
PMID:
37791817
DOI:
10.1080/00952990.2023.2241981
Journal:
American Journal of Drug and Alcohol Abuse
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: